The bill amends the "Uniform Controlled Substances Act" by updating the lists of controlled substances in Schedules I through V. It inserts new language to clarify the substances included in these schedules, which are designated by various names or by the director of the department of health. The bill adds new substances such as Etizolam and Flubromazolam to the list of depressants and expands the list of synthetic cathinones to include Ephylone and Pentylone. It also removes certain introductory language from Schedule II, indicating a reorganization of how substances are categorized.

The bill's purpose is to update the legal framework for controlling substances with potential for abuse. It adds Tramadol and Zolpidem to the controlled substances list, while also deleting unspecified substances. The schedules are organized based on the potential for abuse and accepted medical use, with Schedule I having the highest potential for abuse and no accepted medical use, and Schedule IV having the lowest. The bill specifies limited quantities of narcotic drugs allowed in compounds, mixtures, or preparations and is set to take effect upon passage.

Statutes affected:
5922: 21-28-2.08